CN Stock MarketDetailed Quotes

688247 Sinotherapeutics Inc.

Watchlist
  • 9.10
  • +0.18+2.02%
Market Closed May 31 15:00 CST
4.13BMarket Cap54.17P/E (TTM)

About Sinotherapeutics Inc. Company

The company was founded in August 2012 and is a high-tech enterprise focusing on R&D, commercial production and sales of high-end pharmaceutical preparations. The company is committed to the internationalization of pharmaceutical products and provides cost-effective pharmaceutical products to the global market. The company is a chemical pharmaceutical company participating in international competition. The company's main products include high-end generic drugs and CRO services. Corporate honors: The company has won honors such as “Shanghai Enterprise Technology Center”, “Shanghai Science and Technology Little Giant Enterprise”, “1st Guoxin Cup ESG Golden Bull Award Top 50 Technology Leaders”, and the Shanghai High-tech Achievement Transformation Certificate. It has won honors such as “Jiangsu Specialized, Special and New Small and Medium Enterprises”, “Jiangsu Enterprise Technology Center”, and “Advanced Production Safety Unit” in Haimen Development Zone.

Company Profile

Short Name-A宣泰医药
Company NameSinotherapeutics Inc.
Listing DateAug 25, 2022
Issue Price9.37
Shares Offered45.34M share(s)
FoundedAug 13, 2012
Chairmanjun ye
Legal Representativemingjie guo
General Managermingjie guo
Secretaryfangli li
Employees260
ProvinceShang Hai Shi
Phone021-68819009-606
Office Address1st Floor, Building 3, No. 99 Haike Road, Pudong District, Shanghai
Zip Code201210
Registered AddressRoom 709, 7th Floor, No. 780 Cailun Road, China (Shanghai) Pilot Free Trade Zone
Fax021-68819009-602
Emailinfo@sinotph.com
Business License9131000005124956XX
BusinessLicensed projects: contract manufacturing of pharmaceuticals; retail sale of pharmaceuticals; wholesale of pharmaceuticals. (For projects requiring approval according to law, business activities can only be carried out after approval by the relevant departments; specific business projects are subject to the relevant departments' approval documents or licenses) General projects: Engage in technology development, technology transfer, technical consulting, technical services in the field of pharmaceutical science and technology, import and export business of the enterprise's own products and related technology, wholesale, import and export of chemical raw materials (other than dangerous goods), laboratory equipment and instruments, and provision of related supporting services (excluding auctions), and provision of related supporting services (not involving state-owned trade management products, involving quotas or license management of goods, according to relevant national regulations Apply). (With the exception of projects subject to approval by law, independent business activities are carried out on the basis of a business license in accordance with the law)

Company Executives

  • Name
  • Position
  • Salary
  • jun ye
  • Chairman,directors
  • --
  • JIANSHENG WAN
  • directors,Core technical personnel
  • 575.50K
  • MAOJIAN GU
  • directors,Core technical personnel
  • 294.40K
  • xiaoming ying
  • directors
  • --
  • siyu shen
  • directors
  • --
  • zhijie liu
  • Independent directors
  • 214.30K
  • yong lv
  • Independent directors
  • 214.30K
  • jun zhang
  • Independent directors
  • 214.30K
  • fangli li
  • Board Secretary
  • 691.20K
  • yanqing wang
  • Chairman of the Supervisory Board,auditors
  • --
  • fei xiao
  • auditors
  • --
  • LARRY YUN FANG
  • Deputy General Manager,Core technical personnel
  • 1.34M
  • huafeng wu
  • Deputy General Manager
  • 1.04M
  • kun li
  • Deputy General Manager,Core technical personnel
  • 900.00K
  • jianhong lin
  • Deputy General Manager,Core technical personnel
  • 1.12M
  • peihua wei
  • Head of finance
  • 730.20K
  • hui zhang
  • Employee supervisors
  • 796.60K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg